PATENT CLAIM ANALYSIS

Application Number: 16036001
Application Type: Utility
Filing Date: 2018-07
Publication Date: 2019-05
Patent Classification: ["514", "230500"]

Abstract:
The present invention provides octahydro fused azadecalin compounds and methods of using the compounds as glucocorticoid receptor modulators.

Claim (Index 10):
The compound of  claim 1 , wherein R 1a  is independently selected from the group consisting of hydrogen, C 1-6  alkyl, and C 1-6  haloalkyl.

Metadata:
- Claim Count in Document: 41.0
- Percentile: 95.0
- Lexical Diversity: 1.05556
- Patent Class: 514.0
- Transitional Phrase Type: closed
- Component Type: 1
- Foreign Priority: False
- Related Applications: ['14549885', '15621013', '15013218', '14487347', '13901946']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.8717931362874168
- 35 USC 102 Novelty (BERT): 0.6804106942180188
- Combined Prediction Score: 0.8526548920804771
- Mean Citation Score: 563.652432
- Max Citation Score: 689.4259599999997
- Similarity Product: 686.445814219489

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 0
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test